SKS Technologies (ASX:SKS) Reports Strong 1H25 Performance
SKS Technologies (ASX:SKS) reports a 14.4% revenue increase in 1H25 and projects FY25 revenue of ~$260M.
Tag: Industry-Specific News
SKS Technologies Group Ltd (ASX:SKS) Secures $100 Million Data Centre Project
SKS Technologies Group (ASX:SKS) secures a $100 million data centre project, boosting its pipeline to $220 million.
Rapid Lithium Limited (ASX:RLL) Acquires Two Silver Projects in NSW
Rapid Lithium Limited (ASX:RLL) has entered into a Share Purchase Agreement to acquire Conrad and Webbs Silver Projects in NSW, totaling approximately 34.9 million AgEq ounces.
Fortescue Ltd (ASX:FMG) Updates on Iron Bridge Operation Growth and Future Projections
Fortescue Ltd (ASX:FMG) updates on Iron Bridge’s production expansion, outlining shipment forecasts and future growth targets.
James Hardie Industries plc (ASX:JHX) Releases Annual Asbestos Liability Valuation
James Hardie Industries plc (ASX:JHX) unveils its annual valuation of asbestos-related liabilities, showing an increase to $1,472.4 million and outlining significant financial and regulatory updates.
Brightstar Resources Limited (ASX:BTR) Unveils Expansion Plans
Brightstar Resources (ASX:BTR) announces expansion and development plans to increase gold production and enhance resource base across Western Australia.
Terrain Minerals (ASX:TMX) Commences High-Grade Gold & Silver Drilling
Terrain Minerals (ASX:TMX) starts high-grade gold and silver drilling at Lightning & Monza, alongside a $1.8M rights issue.
Brazilian Rare Earths Limited (ASX:BRE) Secures Strategic Partnership with SENAI CIMATEC
Brazilian Rare Earths Limited (ASX:BRE) secures a strategic partnership with SENAI CIMATEC to develop a pilot plant and laboratory for rare earth beneficiation.
Zoono Group Limited (ASX:ZNO) Secures Exclusive UK Packaging Agreement
Zoono Group Limited (ASX:ZNO) signs an exclusive UK packaging agreement to enhance food shelf-life extension solutions.
Noxopharm Limited (ASX:NOX) Raises $2.5 Million from Nyrada Share Sale
Noxopharm Limited (ASX:NOX) raised $2.5 million through a share sale to fund upcoming clinical trials and R&D initiatives.